InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $71.06 million. The enterprise value is $31.89 million.
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025, before market open.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 26.08 million shares outstanding. The number of shares has increased by 112.45% in one year.
| Current Share Class | 26.08M |
| Shares Outstanding | 26.08M |
| Shares Change (YoY) | +112.45% |
| Shares Change (QoQ) | +34.82% |
| Owned by Insiders (%) | 26.91% |
| Owned by Institutions (%) | 21.54% |
| Float | 13.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.16 |
| Forward PS | 7.70 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.39 |
| Quick Ratio | 5.87 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.75% and return on invested capital (ROIC) is -42.83%.
| Return on Equity (ROE) | -66.75% |
| Return on Assets (ROA) | -37.24% |
| Return on Capital (ROIC) | -42.83% |
| Revenue Per Employee | $103,348 |
| Profits Per Employee | -$427,818 |
| Employee Count | 66 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.46 |
Taxes
In the past 12 months, InspireMD has paid $65,000 in taxes.
| Income Tax | 65,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.97% in the last 52 weeks. The beta is 1.00, so InspireMD's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -10.97% |
| 50-Day Moving Average | 2.77 |
| 200-Day Moving Average | 2.60 |
| Relative Strength Index (RSI) | 46.98 |
| Average Volume (20 Days) | 27,811 |
Short Selling Information
The latest short interest is 170,723, so 0.65% of the outstanding shares have been sold short.
| Short Interest | 170,723 |
| Short Previous Month | 173,645 |
| Short % of Shares Out | 0.65% |
| Short % of Float | 1.26% |
| Short Ratio (days to cover) | 5.80 |
Income Statement
In the last 12 months, InspireMD had revenue of $6.82 million and -$28.24 million in losses. Loss per share was -$0.74.
| Revenue | 6.82M |
| Gross Profit | 1.54M |
| Operating Income | -29.94M |
| Pretax Income | -25.46M |
| Net Income | -28.24M |
| EBITDA | -29.68M |
| EBIT | -29.94M |
| Loss Per Share | -$0.74 |
Full Income StatementBalance Sheet
The company has $40.40 million in cash and $1.23 million in debt, giving a net cash position of $39.17 million or $1.50 per share.
| Cash & Cash Equivalents | 40.40M |
| Total Debt | 1.23M |
| Net Cash | 39.17M |
| Net Cash Per Share | $1.50 |
| Equity (Book Value) | 41.35M |
| Book Value Per Share | 1.61 |
| Working Capital | 39.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.30 million and capital expenditures -$1.31 million, giving a free cash flow of -$20.60 million.
| Operating Cash Flow | -19.30M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | -20.60M |
| FCF Per Share | -$0.79 |
Full Cash Flow StatementMargins
| Gross Margin | 22.61% |
| Operating Margin | -439.00% |
| Pretax Margin | -413.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -112.45% |
| Shareholder Yield | -112.45% |
| Earnings Yield | -39.74% |
| FCF Yield | -28.99% |
Analyst Forecast
The average price target for InspireMD is $4.75, which is 74.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.75 |
| Price Target Difference | 74.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 67.96% |
| EPS Growth Forecast (5Y) | -17.65% |
Stock ForecastsStock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667:1.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667:1 |
Scores
InspireMD has an Altman Z-Score of -3.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.61 |
| Piotroski F-Score | 1 |